Lorviqua 100 mg film-coated tablets, Lorviqua 25 mg film-coated tablets
IFCT-2003
Phase 2 small_molecule active
Quick answer
Lorviqua 100 mg film-coated tablets, Lorviqua 25 mg film-coated tablets for Advanced ROS1-positive non-small cell lung cancer is a Phase 2 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Advanced ROS1-positive non-small cell lung cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active